radiopharmaceuticals

Micrograph showing the most common prostate cancer

Nuclidium raises $99M for copper-based radiopharma pipeline

Nuclidium raised 79 million Swiss francs as the biotech aims to continue the clinical journey of its copper-based diagnostic and therapeutic offering.

James Waldron Jul 10, 2025 5:04am

BerGenBio, following lead drug's failure, merges with Oncoinvent

Jul 1, 2025 7:00am

GE HealthCare's PET agent Vizamyl expands reach in Alzheimer's

Jun 27, 2025 9:45am

Three blocks displaying from left to right a person a handshake and another person

BMS expands radiopharma pipeline

Jun 11, 2025 4:31am

Cellectar seeks strategic alternatives, sinking stock

Apr 30, 2025 10:41am

Telix shows 'promising’ 13-month OS in ph. 2 brain cancer study

Apr 16, 2025 6:30am